Astellas Pharma US Inc is recalling 63,600 vials of Mycamine (micafungin) for Injection 100 mg/vial due to a labeling error regarding the declared strength on the product. This prescription antifungal medication, used to treat various fungal infections, may have incorrect dosage information on the label which could lead to medication errors. Consumers who have this medication should check their lot numbers immediately and consult their healthcare provider or pharmacist.
The labeling error on the declared strength can lead to healthcare providers administering the wrong dose of medication. An incorrect dose of micafungin could result in under-treatment of a serious fungal infection or potential side effects from over-dosage.
Contact healthcare provider and return to pharmacy
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.